# FDA Inspection 1223141 - Bloodworks - October 26, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/bloodworks/446f70d5-c7dc-4a28-bcc1-619bd67bc695/
Source feed: FDA_Inspections

> FDA Inspection 1223141 for Bloodworks on October 26, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223141
- Company Name: Bloodworks
- Inspection Date: 2023-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223141 - 2023-10-26](https://www.globalkeysolutions.net/api/records/fda_inspections/bloodworks/814a52ed-c04d-48e4-acde-964b78007108/)
- [FDA Inspection 1085290 - 2019-03-22](https://www.globalkeysolutions.net/api/records/fda_inspections/bloodworks/e6268635-23bc-4f98-95f6-349223d3207f/)
- [FDA Inspection 1002630 - 2017-02-17](https://www.globalkeysolutions.net/api/records/fda_inspections/bloodworks/ca039b00-2588-49c6-b3c5-d0d366f1b652/)
- [FDA Inspection 1002630 - 2017-02-17](https://www.globalkeysolutions.net/api/records/fda_inspections/bloodworks/6a0bba5a-03a0-426b-8d78-78b383f0c746/)
- [FDA Inspection 913090 - 2015-02-04](https://www.globalkeysolutions.net/api/records/fda_inspections/bloodworks/8d090954-abaa-4460-ad17-86f5ab2e7791/)

Company: https://www.globalkeysolutions.net/companies/bloodworks/2571046d-eb30-4e76-b61d-eb1091b5d36c

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d